Bifogade filer
Kurs & Likviditet
Kalender
2025-05-05 | Årsstämma 2025 |
2025-04-29 | Kvartalsrapport 2025-Q1 |
2025-01-31 | Bokslutskommuniké 2024 |
2024-10-25 | Kvartalsrapport 2024-Q3 |
2024-07-24 | Kvartalsrapport 2024-Q2 |
2024-05-17 | X-dag ordinarie utdelning MCAP 0.00 SEK |
2024-05-06 | Årsstämma 2024 |
2024-05-03 | Kvartalsrapport 2024-Q1 |
2024-01-31 | Bokslutskommuniké 2023 |
2023-10-27 | Kvartalsrapport 2023-Q3 |
2023-07-28 | Kvartalsrapport 2023-Q2 |
2023-05-09 | X-dag ordinarie utdelning MCAP 0.00 SEK |
2023-05-08 | Årsstämma 2023 |
2023-05-03 | Kvartalsrapport 2023-Q1 |
2023-02-10 | Bokslutskommuniké 2022 |
2022-10-28 | Kvartalsrapport 2022-Q3 |
2022-07-29 | Kvartalsrapport 2022-Q2 |
2022-05-10 | X-dag ordinarie utdelning MCAP 0.00 SEK |
2022-05-09 | Årsstämma 2022 |
2022-05-06 | Kvartalsrapport 2022-Q1 |
2022-02-10 | Bokslutskommuniké 2021 |
2021-12-09 | Extra Bolagsstämma 2022 |
2021-10-29 | Kvartalsrapport 2021-Q3 |
2021-07-30 | Kvartalsrapport 2021-Q2 |
2021-05-11 | X-dag ordinarie utdelning MCAP 0.00 SEK |
2021-05-10 | Årsstämma 2021 |
2021-05-07 | Kvartalsrapport 2021-Q1 |
2021-02-19 | Bokslutskommuniké 2020 |
2020-12-14 | Extra Bolagsstämma 2020 |
2020-10-30 | Kvartalsrapport 2020-Q3 |
2020-08-19 | Kvartalsrapport 2020-Q2 |
2020-05-12 | X-dag ordinarie utdelning MCAP 0.00 SEK |
2020-05-11 | Årsstämma 2020 |
2020-05-08 | Kvartalsrapport 2020-Q1 |
2020-02-17 | Bokslutskommuniké 2019 |
2019-10-31 | Kvartalsrapport 2019-Q3 |
2019-08-09 | Kvartalsrapport 2019-Q2 |
2019-05-14 | X-dag ordinarie utdelning MCAP 0.00 SEK |
2019-05-13 | Årsstämma 2019 |
2019-05-10 | Kvartalsrapport 2019-Q1 |
2019-02-15 | Bokslutskommuniké 2018 |
2018-11-02 | Kvartalsrapport 2018-Q3 |
2018-08-10 | Kvartalsrapport 2018-Q2 |
2018-05-22 | X-dag ordinarie utdelning MCAP 0.00 SEK |
2018-05-21 | Årsstämma 2018 |
2018-05-11 | Kvartalsrapport 2018-Q1 |
2018-02-23 | Bokslutskommuniké 2017 |
2017-11-30 | Kvartalsrapport 2017-Q2 |
2017-11-06 | Extra Bolagsstämma 2017 |
2017-09-05 | X-dag ordinarie utdelning MCAP 0.00 SEK |
2017-02-24 | Kvartalsrapport 2017-Q3 |
2016-10-28 | Extra Bolagsstämma 2016 |
2016-09-27 | Split MCAP 10:1 |
2016-09-05 | X-dag ordinarie utdelning MCAP 0.00 SEK |
2016-09-02 | Kvartalsrapport 2017-Q1 |
2016-09-02 | Årsstämma 2017 |
2016-06-10 | Bokslutskommuniké 2016 |
2016-02-26 | Kvartalsrapport 2016-Q3 |
2015-11-30 | Kvartalsrapport 2016-Q2 |
2015-08-31 | X-dag ordinarie utdelning MCAP 0.00 SEK |
2015-08-28 | Årsstämma 2016 |
2015-08-28 | Kvartalsrapport 2016-Q1 |
2015-06-12 | Bokslutskommuniké 2015 |
2015-02-20 | Kvartalsrapport 2015-Q3 |
2014-11-28 | Kvartalsrapport 2015-Q2 |
2014-09-19 | Kvartalsrapport 2015-Q1 |
2014-09-01 | X-dag ordinarie utdelning MCAP 0.00 SEK |
2014-08-29 | Årsstämma 2015 |
2014-06-13 | Bokslutskommuniké 2014 |
2014-02-21 | Kvartalsrapport 2014-Q3 |
2013-11-29 | Kvartalsrapport 2014-Q2 |
2013-09-02 | X-dag ordinarie utdelning MCAP 0.00 SEK |
2013-08-30 | Kvartalsrapport 2014-Q1 |
2013-06-14 | Bokslutskommuniké 2013 |
2013-03-13 | 15-7 2013 |
2013-02-22 | Kvartalsrapport 2013-Q3 |
2012-11-30 | Kvartalsrapport 2013-Q2 |
2012-09-28 | Kapitalmarknadsdag 2012 |
2012-09-03 | X-dag ordinarie utdelning MCAP 0.00 SEK |
2012-08-31 | Kvartalsrapport 2013-Q1 |
2012-08-31 | Årsstämma 2013 |
2012-06-14 | Bokslutskommuniké 2012 |
2012-02-24 | Kvartalsrapport 2012-Q3 |
2012-01-05 | Extra Bolagsstämma 2012 |
2011-11-30 | Kvartalsrapport 2012-Q2 |
2011-08-29 | X-dag ordinarie utdelning MCAP 0.00 SEK |
2011-08-26 | Kvartalsrapport 2012-Q1 |
2011-08-26 | Årsstämma 2012 |
2011-06-14 | Bokslutskommuniké 2011 |
2011-03-01 | Kvartalsrapport 2011-Q3 |
2010-11-30 | Kvartalsrapport 2010-Q3 |
2010-08-30 | X-dag bonusutdelning MCAP 0 |
2010-08-27 | Kvartalsrapport 2010-Q2 |
2010-06-14 | Bokslutskommuniké 2009 |
2010-06-14 | Kvartalsrapport 2010-Q1 |
2010-03-01 | Kvartalsrapport 2009-Q3 |
2009-11-30 | Kvartalsrapport 2009-Q2 |
2009-09-02 | Kvartalsrapport 2009-Q1 |
2009-08-26 | Årsstämma 1 |
Beskrivning
Land | Sverige |
---|---|
Lista | Mid Cap Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
THIS ANNOUNCEMENT IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, IN AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SOUTH AFRICA OR THE UNITED STATES (THE "RESTRICTED JURISDICTIONS"), OR IN ANY OTHER JURISDICTION WHERE SUCH OFFER PURSUANT TO LEGISLATION AND REGULATIONS IN SUCH RELEVANT JURISDICTION WOULD BE PROHIBITED BY APPLICABLE LAW. SHAREHOLDERS NOT RESIDENT IN SWEDEN WHO WISH TO ACCEPT THE OFFER (AS DEFINED BELOW) MUST MAKE INQUIRIES CONCERNING APPLICABLE LEGISLATION AND POSSIBLE TAX CONSEQUENCES. SHAREHOLDERS SHOULD REFER TO THE OFFER RESTRICTIONS INCLUDED IN THE SECTION TITLED "IMPORTANT INFORMATION" AT THE END OF THIS ANNOUNCEMENT AND IN THE OFFER DOCUMENT.
On 17 November 2022, MedCap AB (publ) ("MedCap") announced a recommended public offer to the shareholders of AdderaCare AB (publ) ("AdderaCare") to tender all shares in AdderaCare at a price of SEK 3.60 in cash per share (the "Offer"). The Offer is implemented through Abilia Sverige Holding AB, reg. no. 556682-1251, a subsidiary of MedCap.
The offer document is available on MedCap's website (www.medcap.se) and on Aktieinvest's website (www.aktieinvest.se/emission/adderacare2022). A pre-printed acceptance form and a pre-paid envelope will be distributed to shareholders in AdderaCare whose shares are directly registered with Euroclear Sweden AB on 2 December 2022, subject to applicable offer restrictions.
The acceptance period for the Offer commences on 2 December 2022 and ends on 23 December 2022 (the acceptance period might be extended). Settlement is expected to commence on or around 2 January 2023, provided that the conditions for the Offer have been fulfilled or MedCap has otherwise decided to complete the Offer.
Information regarding the Offer
Information about the Offer is available at: www.medcap.se
Anders Dahlberg, CEO, MedCap
Tel: +46 704 269 262, e-mail: anders.dahlberg@medcap.se
For administrative questions regarding the Offer, please contact primarily your bank or nominee where you have your shares registered.
About MedCap
MedCap builds successful life sciences companies to improve people's lives. MedCap unites the strengths of a larger company with the smaller companies' entrepreneurial power, agility, and business acumen. MedCap is publicly listed on NASDAQ Stockholm OMX, with the symbol MCAP. More information is available on the company web site www.medcap.se.
The information in this press release has been published by MedCap, through the agency of the contact person, in accordance with the Takeover Rules. This press release was submitted for publication on 1 December 2022, at 8.30 (CET).
THIS PRESS RELEASE HAS BEEN PUBLISHED IN SWEDISH AND ENGLISH. IN THE EVENT OF ANY DISCREPANCY BETWEEN THE LANGUAGE VERSIONS, THE SWEDISH VERSION SHALL PREVAIL.
THE OFFER IS NOT MADE, EITHER DIRECTLY OR INDIRECTLY, IN THE RESTRICTED JURISDICTIONS OR IN ANY OTHER JURISDICTION WHERE SUCH OFFER WOULD BE PROHIBITED UNDER APPLICABLE LAW, BY MAIL OR OTHER MEANS OF COMMUNICATION (INCLUDING, BUT NOT LIMITED TO, TELEFAX, E-MAIL, TELEX, TELEPHONE AND INTERNET) USED IN DOMESTIC OR INTERNATIONAL COMMERCE OR AT ANY NATIONAL EXCHANGE OR TRADING FACILITY IN THE RESTRICTED JURISDICTIONS, AND THE OFFER CANNOT BE ACCEPTED IN ANY SUCH MANNER OR BY ANY SUCH MEANS OF COMMUNICATION IN OR FROM THE RESTRICTED JURISDICTIONS. THEREFORE, NEITHER THIS PRESS RELEASE NOR OTHER DOCUMENTATION RELATING TO THE OFFER WILL BE, AND SHALL NOT, BE SENT, POSTED OR OTHERWISE DISSEMINATED OR FORWARDED IN OR TO THE RESTRICTED JURISDICTIONS.
THIS PRESS RELEASE IS NOT, AND MAY NOT BE, SENT TO SHAREHOLDERS WITH REGISTERED ADDRESSES IN THE RESTRICTED JURISDICTIONS. BANKS, BROKERS, TRADERS AND OTHER NOMINEES HOLDING SHARES FOR PERSONS IN THE RESTRICTED JURISDICTION MAY NOT FORWARD THIS PRESS RELEASE, OR ANY OTHER DOCUMENT RECEIVED IN CONNECTION WITH THE OFFER, TO SUCH PERSONS. "UNITED STATES" IN THIS SECTION MEANS THE UNITED STATES OF AMERICA (ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES, AND THE DISTRICT OF COLUMBIA).
THE OFFER AND THE INFORMATION, AND DOCUMENTATION MADE AVAILABLE THROUGH THIS PRESS RELEASE HAVE NOT BEEN PREPARED BY, AND NOT APPROVED BY, AN "AUTHORIZED PERSON" AS REFERRED TO IN SECTION 21 OF THE UK FINANCIAL SERVICES AND MARKETS ACT 2000 ("FSMA"). ACCORDINGLY, THE INFORMATION AND DOCUMENTS MADE AVAILABLE THROUGH THIS PRESS RELEASE MAY NOT BE DISTRIBUTED TO, OR FORWARDED TO, THE PUBLIC IN THE UK. DISSEMINATION OF INFORMATION AND DOCUMENTS MADE AVAILABLE THROUGH THIS PRESS RELEASE IS EXEMPT FROM THE RESTRICTIONS ON FINANCIAL MARKETING IN ARTICLE 21 OF THE FSMA ON THE BASIS THAT IT IS A COMMUNICATION BY OR ON BEHALF OF A LEGAL PERSON RELATING TO A TRANSACTION FOR THE ACQUISITION OF THE DAY-TO-DAY CONTROL OF THE BUSINESS OF THE LEGAL ENTITY, OR TO ACQUIRE 50 PER CENT OR MORE OF THE VOTING SHARES IN A LEGAL ENTITY, IN ACCORDANCE WITH ARTICLE 62 OF THE FSMA (FINANCIAL PROMOTION) ORDER 2005.
STATEMENTS IN THIS PRESS RELEASE RELATING TO FUTURE CONDITIONS OR CIRCUMSTANCES, INCLUDING INFORMATION REGARDING FUTURE PERFORMANCE, GROWTH AND OTHER TREND PROJECTIONS AND THE OTHER BENEFITS OF THE OFFER, ARE FORWARD-LOOKING STATEMENTS. THESE STATEMENTS MAY GENERALLY, BUT NOT ALWAYS, BE IDENTIFIED BY THE USE OF WORDS SUCH AS "ANTICIPATES", "INTENDS", "EXPECTS", "BELIEVES" OR SIMILAR EXPRESSIONS. BY THEIR NATURE, FORWARD-LOOKING STATEMENTS INVOLVE RISK AND UNCERTAINTY BECAUSE THEY RELATE TO EVENTS THAT ARE DEPENDENT ON CIRCUMSTANCES THAT OCCUR IN THE FUTURE. DUE TO A NUMBER OF FACTORS, WHICH TO A LARGE EXTENT ARE BEYOND THE CONTROL OF MEDCAP, IT CANNOT BE GUARANTEED THAT FUTURE CONDITIONS WILL NOT DIFFER MATERIALLY FROM THOSE EXPRESSED OR IMPLIED BY THE FORWARD-LOOKING STATEMENTS. ANY SUCH FORWARD-LOOKING STATEMENT SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE ANNOUNCED AND MEDCAP HAS NO OBLIGATION (AND UNDERTAKES NO SUCH OBLIGATION) TO UPDATE OR REVISE ANY OF THEM, WHETHER AS A RESULT OF NEW INFORMATION, FUTURE EVENTS OR OTHERWISE, EXCEPT IN ACCORDANCE WITH APPLICABLE LAWS AND REGULATIONS.